Buscar
Mostrando ítems 4371-4380 de 15820
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
(Sci Immunol, 2022)
Life-threatening ‘breakthrough’ cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS-CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing ...
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
(Sci Immunol, 2022)
Life-threatening 'breakthrough' cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS-CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing ...
Antigenic original sin: a challenge for the design of new vaccines against SARS-CoV-2?El pecado original antigénico: un desafio para el diseño de nuevas vacunas contra el SARS-CoV-2?
(Universidad Centroccidental Lisandro Alvarado, 2022)
Vacunación Contra el Virus del Papiloma Humano y Autoinmunidad
Development of autoimmune diseases is a very important issue in relation to vaccines, because there is a risk that they might promote autoimmune phenomena in susceptible individuals. The risk: benefit ratio of developing ...
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebocontrolled, phase 2 trial
Background This is the first randomised controlled trial for assessment of the immunogenicity and safety of a
candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate
dose ...
Evaluación de la respuesta postvacunal a peste porcina clásica por medio de diferentes pruebas diagnósticas en cerdos desafiados experimentalmente
(2011)
El propósito de este trabajo fue evaluar dos vacunas comerciales de Peste Porcina Clásica (PPC) utilizadas en Colombia elaboradas con la cepa China. El diseño experimental consistió en un grupo de treinta (30) cerdos ...
Avaliação da eficiência de vacinas antitetânicas de uso veterinário
(Universidade Federal de Minas GeraisUFMG, 2006-04-27)
Tetanus is an infectious neurological syndrome caused by the action of the tetanus toxin, produced by Clostridium tetani, which acts in the central nervous system, characterizing itself for a spastic paralysis. The antibody ...
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
(2013-06-01)
Given that cancer is one of the main causes of death worldwide, many efforts have been directed toward discovering new treatments and approaches to cure or control this group of diseases. Chemotherapy is the main treatment ...
Short Report: Vaccinia Virus in Humans and Cattle in Southwest Region of São Paulo State, Brazil
(Amer Soc Trop Med & Hygiene, 2008-11-01)
A new outbreak of Vaccinia virus was observed in Southwest region of São Paulo State. Brazil. The disease was observed in four small dairy farms with manual milking. Lesions were detected in cattle and in humans previously ...